|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
1995-12-12
|
|
pubmed:abstractText |
Cytomegalovirus is a frequent cause of infection and morbidity after heart transplantation, especially in patients treated with antilymphocytic drugs where the incidence may be as high as 50%.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1053-2498
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
14
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
659-65
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:7578172-Acyclovir,
pubmed-meshheading:7578172-Administration, Oral,
pubmed-meshheading:7578172-Adolescent,
pubmed-meshheading:7578172-Adult,
pubmed-meshheading:7578172-Aged,
pubmed-meshheading:7578172-Antiviral Agents,
pubmed-meshheading:7578172-Combined Modality Therapy,
pubmed-meshheading:7578172-Cytomegalovirus Infections,
pubmed-meshheading:7578172-Dose-Response Relationship, Drug,
pubmed-meshheading:7578172-Drug Administration Schedule,
pubmed-meshheading:7578172-Female,
pubmed-meshheading:7578172-Ganciclovir,
pubmed-meshheading:7578172-Graft Rejection,
pubmed-meshheading:7578172-Heart Transplantation,
pubmed-meshheading:7578172-Humans,
pubmed-meshheading:7578172-Immunosuppressive Agents,
pubmed-meshheading:7578172-Infusions, Intravenous,
pubmed-meshheading:7578172-Male,
pubmed-meshheading:7578172-Middle Aged,
pubmed-meshheading:7578172-Muromonab-CD3,
pubmed-meshheading:7578172-Opportunistic Infections,
pubmed-meshheading:7578172-Postoperative Complications,
pubmed-meshheading:7578172-Retrospective Studies
|
|
pubmed:articleTitle |
Combined antiviral and immunoglobulin therapy as prophylaxis against cytomegalovirus infection after heart transplantation.
|
|
pubmed:affiliation |
Division of Cardiothoracic Surgery, Cedars-Sinai Medical Center, Los Angeles 90048, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
